|
HY-12855A-100mg
|
MedChemexpress LLC
|
Lys05 [CAS 1391426-24-6]
|
|
Cancer-programmed cell death
|
|
|
HY-12855A-5mg
|
MedChemexpress LLC
|
Lys05 [CAS 1391426-24-6]
|
|
Cancer-programmed cell death
|
|
|
HY-12855A-50mg
|
MedChemexpress LLC
|
Lys05 [CAS 1391426-24-6]
|
|
Cancer-programmed cell death
|
|
|
HY-12855A-1mL
|
MedChemexpress LLC
|
Lys05 [CAS 1391426-24-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-N2213-1mg
|
MedChemexpress LLC
|
Matairesinol 4?-O-Beta-D-glucopyranoside [CAS 106647-14-7]
|
|
Cancer-programmed cell death
|
|
|
HY-N2213-10mg
|
MedChemexpress LLC
|
Matairesinol 4?-O-Beta-D-glucopyranoside [CAS 106647-14-7]
|
|
Cancer-programmed cell death
|
|
|
HY-N2213-5mg
|
MedChemexpress LLC
|
Matairesinol 4?-O-Beta-D-glucopyranoside [CAS 106647-14-7]
|
|
Cancer-programmed cell death
|
|
|
HY-P1205A-10mg
|
MedChemexpress LLC
|
MCH(human, mouse, rat) (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1205A-5mg
|
MedChemexpress LLC
|
MCH(human, mouse, rat) (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-19972-1mg
|
MedChemexpress LLC
|
ML243 [CAS 1426576-80-8]
|
|
Cancer-programmed cell death
|
|
|
HY-16967-10mg
|
MedChemexpress LLC
|
MM41 [CAS 1429028-96-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16967-100mg
|
MedChemexpress LLC
|
MM41 [CAS 1429028-96-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16967-25mg
|
MedChemexpress LLC
|
MM41 [CAS 1429028-96-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16967-5mg
|
MedChemexpress LLC
|
MM41 [CAS 1429028-96-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16967-50mg
|
MedChemexpress LLC
|
MM41 [CAS 1429028-96-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16967-1mL
|
MedChemexpress LLC
|
MM41 [CAS 1429028-96-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P1037-1mg
|
MedChemexpress LLC
|
Motilin (26-47), human, porcine [CAS 52906-92-0]
|
|
|
|
|
HY-P1037-5mg
|
MedChemexpress LLC
|
Motilin (26-47), human, porcine [CAS 52906-92-0]
|
|
|
|
|
HY-P1037-500ug
|
MedChemexpress LLC
|
Motilin (26-47), human, porcine [CAS 52906-92-0]
|
|
|
|
|
CG015
|
Virusys Corporation
|
CMV Antigen Slide
|
Virus
|
IF
|
|
|
EG039
|
Virusys Corporation
|
EBV Antigen Slide (8 well)
|
|
|
|
|
H1G028
|
Virusys Corporation
|
HSV-1 Antigen Slides
|
Virus
|
IF
|
|
|
H2G029
|
Virusys Corporation
|
HSV-2 Antigen Slides
|
Virus
|
IF
|
|
|
VG038
|
Virusys Corporation
|
VZV Antigen Slide
|
Virus
|
IF
|
|
|
sc-391074
|
Santa Cruz Biotechnology
|
White Line Inducing Principle [WLIP] [CAS 135096-89-8]
|
|
|
|
